甲状旁腺全切除加前臂自体移植术治疗肾性继发性甲状旁腺功能亢进的长期疗效

doi:10.16139/j.1007-9610.2018.06.012

外科理论与实践 ›› 2018, Vol. 23 ›› Issue (06): 523-527.doi: 10.16139/j.1007-9610.2018.06.012

甲状旁腺全切除加前臂自体移植术治疗肾性继发性甲状旁腺功能亢进的长期疗效

王红鹰^a, 黄骏文^a, 邹强^a, 陈靖^b, 张敏敏^b, 张炜晨^b, 劳正胤^c

复旦大学附属华山医院 a.普外科,b.肾内科,c.健康管理中心,上海 200040

收稿日期:2018-06-26 出版日期:2018-11-25 发布日期:2020-07-25
通讯作者: 劳正胤,E-mail: 13816477647@163.com
基金资助:
上海市科学技术委员会科研计划项目（14411 966100）

Long-term outcome of total parathyroidectomy with autotransplantation in treatment of renal secondary hyperparathyroidism

WANG Hongying^a, HUANG Junwen^a, ZOU Qiang^a, CHEN Jing^b, ZHANG Minmin^b, ZHANG Weichen^b, LAO Zhengyin^c

a. Department of General Surgery, b. Department of Nephrology, c. Health Management Centre, Huashan Hospital, Fudan University, Shanghai 200040, China

Received:2018-06-26 Online:2018-11-25 Published:2020-07-25

摘要/Abstract

摘要： 目的: 探究甲状旁腺全切除加前臂自体移植术（total parathyroidectomy with forearm autotransplantation, TPTX+AT）治疗肾性继发性甲状旁腺功能亢进（secondary hyperparathyroidism, SHPT）术后长期疗效。方法: 我院1999年1月至2017年11月行TPTX+AT的SHPT病人124例,分析术后症状改善和血钙、磷、全段甲状旁腺激素（intact parathyroid hormones, iPTH）水平变化,以及术后复发率、持续性甲状旁腺功能低下发生率、死亡率等。结果: 术后病人临床症状均明显改善。术后1个月病人血钙、磷、iPTH及碱性磷酸酶水平均较术前明显降低（均P<0.05）,基本可长期控制在正常水平。随访至2018年5月,10例（8.06%）复发,7例（5.64%）发生持续性甲状旁腺功能低下,19例（15.32%）死亡。结论: TPTX+AT治疗SHPT能长期有效地缓解症状,改善钙磷代谢。术后复发率与持续性甲状旁腺功能低下发生率、死亡率均在较低水平。

关键词: 甲状旁腺全切除加前臂自体移植术, 慢性肾脏病, 继发性甲状旁腺功能亢进症

Abstract: Objective To explore the long-term outcome of total parathyroidectomy with forearm autotransplantation (TPTX+AT) in the treatment of patients with secondary hyperparathyroidism (SHPT) of renal disease. Methods A total of 124 patients with SHPT were subjected to TPTX+AT from January 1999 to November 2017 and were analyzed. The clinical data including symptom relief, calcium, phosphate and intact parathyroid hormone (iPTH) in serum before and after the surgery were collected. Recurrence rate, persistent hypoparathyroidism and mortality rate were analyzed. Results After operation, symptoms relieved significantly. Calcium, phosphate and iPTH in serum decreased significantly 1 month postoperative when compared those preoperative, and could be maintained well for a long period. It was shown that 10 patients(8.06%) had recurrence, 7 patients(5.64%) had persistent hypoparathyroidism and 19 patients (15.32%) died after follow-up until to May 2018. Conclusions TPTX+AT could be performed to treat patients with SHPT that relieves symptoms effectively and improves calcium and phosphorus metabolism for a long period. Recurrence rate, persistent hypoparathyroidism and mortality might be maintained at a lower level.

Key words: Total parathyroidectomy with forearm autotransplantation, Chronic kidney diseases, Secondary hyperparathyroidism

中图分类号:

R653

王红鹰, 黄骏文, 邹强, 陈靖, 张敏敏, 张炜晨, 劳正胤. 甲状旁腺全切除加前臂自体移植术治疗肾性继发性甲状旁腺功能亢进的长期疗效[J]. 外科理论与实践, 2018, 23(06): 523-527.

WANG Hongying, HUANG Junwen, ZOU Qiang, CHEN Jing, ZHANG Minmin, ZHANG Weichen, LAO Zhengyin. Long-term outcome of total parathyroidectomy with autotransplantation in treatment of renal secondary hyperparathyroidism[J]. Journal of Surgery Concepts & Practice, 2018, 23(06): 523-527.

参考文献

[1] Yuen NK, Ananthakrishnan S, Campbell MJ.Hyperparathyroidism of renal disease[J]. Perm J,2016,20(3):78-83.
[2] Zhang L, Wang F, Wang L, et al.Prevalence of chronic kidney disease in China: a cross-sectional survey[J]. Lancet,2012,379(9818):815-822.
[3] 卞维静, 王国勤, 罗洋, 等. 长期血液透析患者继发性甲状旁腺功能亢进症的流行病学分析[J]. 中日友好医院学报,2008,22(4):195-197.
[4] 田文, 贺青卿, 姜可伟, 等. 慢性肾功能衰竭继发甲状旁腺功能亢进外科临床实践专家共识[J]. 中国实用外科杂志,2016,36(5):481-486.
[5] Tominaga Y, Matsuoka S, Uno N, et al.Removal of autografted parathyroid tissue for recurrent renal hyperparathyroidism in hemodialysis patients[J]. World J Surg,2010,34(6):1312-1317.
[6] Dotzenrath C, Cupisti K, Goretzki E, et al.Operative treatment of renal autonomous hyperparathyroidism: cause of persistent or recurrent disease in 304 patients[J]. Langenbecks Arch Surg,2003,387(9-10):348-354.
[7] 王莉, 李贵森, 刘志红. 中华医学会肾脏病学分会《慢性肾脏病矿物质和骨异常诊治指导》[J]. 肾脏病与透析肾移植杂志,2013,22(6):554-559.
[8] Tentori F, Wang M, Bieber BA, et al.Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study[J]. Clin J Am Soc Nephrol,2015,10(1):98-109.
[9] Masakane I, Kawanishi H, Mineshima M, et al.2011 JSDT standard on the management of endotoxin retentive filter for dialysis and related therapies[J]. Ther Apher Dial,2013,17(2):229-240.
[10] Kidney disease: improving global outcomes (KDIGO) CKD-MBD update work group. KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mi-neral and bone disorder(CKD-MBD)[J]. Kidney Int Suppl,2017,7(1):1-59.
[11] He Q, Zhuang D, Zheng L, et al.Total parathyroidectomy with trace amounts of parathyroid tissue autotransplantation as the treatment of choice for secondary hyperparathyroidism: a single-center experience[J]. BMC Surg,2014,14:26.
[12] Yuan LL, Kan Y, Ma DQ, et al.Combined application of ultrasound and SPECT/CT has incremental value in detecting parathyroid tissue in SHPT patients[J]. Diagn Interv Imaging,2016,97(2):219-225.
[13] Lirov R, Worden FP, Cohen MS.The treatment of advanced thyroid cancer in the age of novel targeted therapies[J]. Drugs,2017,77(7):733-745.
[14] Floege J, Kim J, Ireland E, et al.Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population[J]. Nephrol Dial Transplant,2011,26(6):1948-1955.
[15] 杨昱, 沈世凯, 张健. 甲状旁腺全切除自体前臂移植术治疗肾功能不全继发性甲状旁腺功能亢进[J]. 中国普通外科杂志,2016,25(5):643-647.
[16] Sun Y, Cai H, Bai J, et al.Endoscopic total parathyroidectomy and partial parathyroid tissue autotransplantation for patients with secondary hyperparathyroidism: a new surgical approach[J]. World J Surg,2009,33(8):1674-1679.
[17] Agha A, Loss M, Schlitt HJ, et al.Recurrence of se-condary hyperparathyroidism in patients after total parathyroidectomy with autotransplantation: technical and therapeutic aspects[J]. Eur Arch Otorhinolaryngol,2012, 269(5):1519-1525.
[18] Neagoe RM, Muresan M, Voidãzan S, et al.Subtotal parathyroidectomy versus total parathyroidectomy with autotransplant in secondary hyperparathyroidism-a single-centre prospective cohort of 43 patients[J]. Endokrynol Pol,2016,67(2):202-209.
[19] Tominaga Y. Management of renal hyperparathyroidism[J]. Biomed Pharmacother,2000,54 Suppl 1:25s-31s.
[20] Chen JB, Chou FF, Yang CH, et al.Association between clinical variables and mortality after parathyroidectomy in maintenance hemodialysis patients[J]. Am J Surg,2017, 213(1):140-145.

甲状旁腺全切除加前臂自体移植术治疗肾性继发性甲状旁腺功能亢进的长期疗效

Long-term outcome of total parathyroidectomy with autotransplantation in treatment of renal secondary hyperparathyroidism

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	章晓炎, 徐静, 璩斌. 血清维生素D水平对老年慢性肾脏病患者肾功能的影响[J]. 内科理论与实践, 2022, 17(04): 307-312.
[2]	轩应利, 陈斐虹, 秦丽, 和瑞斌, 庞诗情, 袁江姿. 维生素D与慢性肾脏病患者夜间血压的相关性分析[J]. 内科理论与实践, 2021, 16(04): 246-250.
[3]	杨聚荣, 林利容. 慢性肾脏病患者妊娠的管理现状及策略[J]. 诊断学理论与实践, 2021, 20(02): 125-129.
[4]	范秋灵. 糖尿病肾病和非糖尿病慢性肾脏病患者应用钠-葡萄糖协同转运蛋白2抑制剂：预后评估及相关指南解读[J]. 诊断学理论与实践, 2021, 20(02): 130-137.
[5]	陈晓农, 高琛妮. 肾性贫血的诊治进展[J]. 内科理论与实践, 2021, 16(01): 10-14.
[6]	晏焕青, 谢琼虹, 尚达, 戴淑琪, 朱彤莹. 胎球蛋白A对腹膜透析患者冠状动脉钙化发生起始的影响因素分析[J]. 内科理论与实践, 2021, 16(01): 49-52.
[7]	余舒文, 方正滢, 谢静远. 基因检测在慢性肾脏病诊治中的应用及进展[J]. 诊断学理论与实践, 2020, 19(06): 613-617.
[8]	李贵森. 2019年《中国慢性肾脏病矿物质和骨异常诊治指南》解读[J]. 诊断学理论与实践, 2020, 19(03): 229-231.
[9]	李娅, 徐静, 张春丽, 王朝晖, 王伟铭,. IgA肾病患者清晨高血压与肾功能关系的研究[J]. 内科理论与实践, 2020, 15(01): 45-48.
[10]	毕宇芳,. 2型糖尿病合并慢性肾脏病患者口服降糖药治疗中国专家共识（2019年更新版）解读[J]. 内科理论与实践, 2019, 14(06): 333-336.
[11]	王媛媛, 范秋灵. 血清降钙素原在慢性肾脏病合并细菌感染患者中的临床价值[J]. 诊断学理论与实践, 2019, 18(03): 353-359.
[12]	田滨瑶, 徐天华, 姚丽,. 继发性甲状旁腺功能亢进的治疗与进展[J]. 内科理论与实践, 2018, 13(04): 250-254.
[13]	陈晓农, 汪知玉,. 新型骨相关生物标志物在慢性肾脏病血管钙化中的应用价值[J]. 内科理论与实践, 2018, 13(04): 202-206.
[14]	赵雪, 陈丽萌,. 慢性肾脏病矿物质和骨异常患者骨折风险评估及临床意义[J]. 内科理论与实践, 2018, 13(04): 244-249.
[15]	张春燕, 汪知玉, 杨俪, 黄晓敏, 施咏梅, 王朝晖, 任红, 陈晓农,. “学校式”磷教育在腹膜透析高磷患者中的运用[J]. 内科理论与实践, 2018, 13(04): 227-230.